AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Jul 31, 2014
30016_dirs_2014-07-31_a5a8fadf-e2ec-4708-b7ea-8db2de65e98e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-07-30
Reporting Person: AYERS JONATHAN W (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-07-30 | Common Stock | M | 10000 | $34.3700 | Acquired | 406036 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-30 | Non-Qualified Stock Option (right to buy) | $34.3700 | M | 10000 | Disposed | 2016-02-13 | Common Stock (10000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 49000 | Indirect |
Footnotes
F1: Includes 59 shares and 51 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 03/31/2014 and 06/30/2014, respectively.
F2: Grant of options to buy shares of common stock exercisable as to 15,999 shares on each of 02/14/2010 and 02/14/2013, 16,000 shares on each of 02/14/2011 and 02/14/2012 and 13,091 shares on 02/14/2014.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26